Gary Culliton reports on remarks made by Associate Prof Cathy Eng, Medical Oncologist at the University of Texas MD Anderson Cancer Centre, at the recent Mater Hospital ‘Multimodality Management of Colorectal Liver Metastases: Collaborating Towards Cure’ meeting.
Routine surveillance of patients with Barrett’s oesophagus is of “doubtful value”, experts say, with research showing very few patients will develop oesophageal cancer.
New research has shed light on why some breast-cancer patients experience neurological impairments, with evidence that certain areas of the brain are particularly vulnerable to chemotherapy.
The debate on whether non-steroidal anti-inflammatory drugs (NSAIDs) have a chemopreventive role to play have resurfaced, with the latest analysis finding users of NSAIDs have a significantly reduced risk for oesophageal cancers.
Dr John Greene and Prof Bryan Hennessy look at the role of anthracyclines in the treatment of breast cancer and how careful monitoring can limit any potential for cardiotoxicity.
Many women did not regain their pre-morbid physical activity levels several years after ovarian cancer diagnosis, new research shows.
Each 10g increase in dietary and cereal fibre intake reduces an individual’s risk of colorectal cancer (CRC) by about 10 per cent, but fibre from fruit and vegetables contributes little to the risk reduction, a large meta-analysis concludes.
Most claims from cancer survivors that mammography screenings saved their lives are unfounded, a study suggests, after finding the test has only a minor impact on mortality.
Intrauterine device (IUD) use might act as a protective cofactor in cervical carcinogenesis, a new study has found. Cellular immunity triggered by the device might be one of several mechanisms that could explain findings by a Catalan group led by Dr Xavier Castellsagué.
Gary Culliton reports on a recent meeting on ‘Advances in Ovarian Cancer’, where delegates got the latest updates on clinical trials into the causes and treatment of the disease.
Loading ...
